2 brilliant growth shares I’d buy in July

Royston Wild looks at two stocks with white-hot growth prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

EKF Diagnostics (LSE: EKF) was setting the pace in Thursday business following the release of terrific trading details.

The medical play was last 8% higher on the day after hitting two-and-a-half-year peaks of 26p per share earlier in the session.

EKF announced that “trading in the second quarter of the year has continued the favourable trends experienced in the first quarter,” adding that Junes sales had been particularly strong. The Cardiff business said that this “is entirely due to organic growth with no major tenders won during the period.”

As a result, the AIM-listed firm advised that adjusted EBITDA for 2017 should ring in “comfortably ahead” of current projections.

And to round off a perky announcement, the blood testing star declared that, as a result of strong cash generation, that net cash as of June 30 stood at £4m. This is a vast upgrade from net cash of £2.2m posted at the end of 2016.

Set to bounce?

The City had already been predicting strong bottom-line growth prior to today’s release, forecasts pointing to pre-tax profit of £3.6m versus last year’s £1m loss. And profits were expected to tip to £4m in 2018.

But today’s release is likely to lead to seismic upgrades to these numbers in the near term. And further upward revisions are very likely should EKF keep up the momentum. As such, I reckon the stock is a great pick despite its conventionally-high forward P/E ratio of 31.3 times.

A champion boxer

DS Smith (LSE: SMDS) is another London growth giant that investors should take a close look at.

The company has proven to be a reliable growth generator for some years now, and the number crunchers expect further expansion of 3% and 6% in 2017 and 2018 respectively. These figures also make it decent value for money, sporting a prospective P/E rating of just 14.5 times.

The box-builder’s stock value also exploded recently after the release of perky financials, the London business gaining fuel after last week’s full-year results and striding to fresh record peaks above 485p per share just today.

DS Smith declared that revenues detonated 18% in 2016, to £4.9bn, a result that powered adjusted pre-tax profit 18% higher to £391m. While sterling weakness gave the top line a welcome boost, this does not tell the whole story as sales at constant currencies still rose by a healthy 6% year-on-year.

The packager’s programme of spreading its wingspan across the continent continues to pay off handsomely. It noted “continued excellent growth from pan-European customers” and enjoyed growth in all of its regions last year.

DS Smith shelled out £85m on acquisitions last year alone, and its appetite for M&A shows no signs of waning. The company has also bought an 80% stake in Interstate Resources this month for £722m, with an option to buy the remaining share within five years, in a move that marks its first foray into the massive US market.

I am confident the huge investment it is making to bolster its global footprint and position in key growth areas should continue to deliver meaty earnings growth in the years ahead.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended DS Smith. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »